OneAscent Wealth Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,169
Closed -$200K 166
2022
Q3
$200K Buy
6,169
+742
+14% +$30.6K 0.1% 145
2022
Q2
$214K Buy
+5,427
New +$290K 0.11% 159
2021
Q4
Sell
-4,390
Closed -$419K 96
2021
Q3
$419K Buy
+4,390
New +$464K 0.48% 47
2021
Q1
$648K Buy
4,917
+636
+15% +$87.1K 0.28% 87
2020
Q4
$567K Buy
+4,281
New +$518K 0.26% 91

Other funds holding EXAS

OneAscent Wealth Management's EXAS Position: Q4 2022 in Review

OneAscent Wealth Management sold out of Exact Sciences (EXAS) in Q4 2022, closing a stake of 6,169 shares — an estimated $200K sold.

OneAscent Wealth Management first reported a position in EXAS in Q4 2020 and held it in 5 quarters. The position peaked at $648K in Q1 2021. 551 funds tracked by Wall St. Rank hold EXAS as of Q4 2022.

  • OneAscent Wealth Management reported no remaining Exact Sciences position as of Q4 2022 after selling out during the quarter.
  • OneAscent Wealth Management sold 6,169 Exact Sciences shares in Q4 2022, an estimated $200K.
  • OneAscent Wealth Management first reported a position in Exact Sciences in Q4 2020 and held it in 5 quarters.
  • OneAscent Wealth Management's Exact Sciences position peaked at $648K in Q1 2021.
  • 551 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2022.

Based on OneAscent Wealth Management's 13F filing for Q4 2022, filed 12 Jan 2023.